Blocking an inflammatory pathway may offer a new way to treat autoimmune disease.

Learn how Novartis is using technology to improve the oncology clinical trial process.

Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.

Our Global Head of Patient Affairs and Policy shares why it’s critical to engage patients throughout the drug development process.

Meet our Vice President of Strategic Data and Digital at Novartis Oncology.

Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.

The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.